Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 12, 2023 8-K
4 Aug 17, 2023 OWNERSHIP DOCUMENT
4 Aug 17, 2023 OWNERSHIP DOCUMENT
4 Aug 17, 2023 OWNERSHIP DOCUMENT
4 Aug 17, 2023 OWNERSHIP DOCUMENT
S-8 Aug 11, 2023 FORM S-8
10-Q Aug 7, 2023 10-Q
8-K Aug 7, 2023 8-K
8-K Jul 13, 2023 8-K
424B3 Jul 7, 2023 424B3
8-K Jun 29, 2023 8-K
DEFA14A Jun 28, 2023 DEFA14A
8-K May 30, 2023 8-K
ARS May 19, 2023 ARS
DEF 14A May 18, 2023 DEF 14A
8-K May 18, 2023 8-K
8-K May 10, 2023 8-K
8-K May 5, 2023 8-K
10-Q May 4, 2023 10-Q
8-K May 4, 2023 8-K
PRE 14A May 2, 2023 PRE 14A
10-K/A May 1, 2023 10-K/A
424B5 Feb 27, 2023 424B5
8-K Feb 27, 2023 8-K
10-K Feb 27, 2023 10-K
← Newer Page 5 of 38 · 935 filings Older →